NOXCOVID has been cleared to recruit patients for the 800 mg and 1200 mg cohorts, which means that there were no safety concerns with the 400 mg and 600 mg groups. The announcement did not comment on efficacy.
On the same day, Noxopharm announced the formation of a dedicated subsidiary to exploit its STING-inhibition technology.
Coincidence?
- Forums
- ASX - By Stock
- Join the dots
NOX
noxopharm limited
Add to My Watchlist
0.00%
!
9.8¢

NOXCOVID has been cleared to recruit patients for the 800 mg and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.63M |
Open | High | Low | Value | Volume |
9.7¢ | 9.8¢ | 9.5¢ | $15.43K | 159.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47773 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 47899 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47773 | 0.093 |
2 | 17198 | 0.092 |
1 | 10989 | 0.091 |
1 | 10000 | 0.090 |
1 | 20000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 47899 | 1 |
0.099 | 90000 | 1 |
0.105 | 31954 | 1 |
0.110 | 251000 | 5 |
0.115 | 55816 | 3 |
Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |